Imophoron
Bristol, United Kingdom · Founded 2017 · $4.9M raised
- Headquarters
- Bristol
- Founded
- 2017
- Business Model
- B2B
- Website
- imophoron.com
- Total Funding
- $4.9M
- Last Round
- $4.9M SeedOct 2021
- Rounds
- 1
About
Imophoron is a Bristol, UK-based biotech startup spun out of the University of Bristol in 2017, co-founded by Professor Imre Berger and Frederic Garzoni. The company has developed a novel next-generation nanoparticle platform technology for rapid and cost-effective vaccine development, targeting pharmaceutical and other industries worldwide. Imophoron received 4 million GBP in funding in 2021 and has partnered with organizations including eXmoor Pharma for process development, with applications spanning pandemic preparedness and beyond.
Summary
Imophoron is a Biotech company based in Bristol, United Kingdom, founded in 2017. It has raised $4.9M in total across 1 round, most recently a $4.9M Seed round in Oct 2021.
Funding History
Oct 2021
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/imophoron"><img src="https://indexed.vc/api/badge/company/imophoron" alt="Imophoron on Indexed.vc" width="260" height="76" /></a>